- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03664817
Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Young black men who have sex with men (YBMSM) have high rates of HIV infection, and are also at risk for falling out of clinical care. Social capital, which refers to the resources in a person's social network, has been shown to be beneficial for people living with HIV in other places. The study wants to understand and build upon social capital in the YBMSM population in Atlanta, with the goal of ultimately improving HIV-related outcomes for these youth.
To achieve this study is conducted in 3 phases. In Phase I, study will conduct interviews with YBMSM and community leaders to get advice about developing a social capital intervention that will improve social capital. Phase II is a randomized controlled trial of groups of YBMSM implementing the social capital intervention versus groups of YBMSM receiving a general health promotion intervention (Health for Life; H4L). This is followed by Phase III which is mainly to measure the social capital and engagement in care with the HIV-positive YBMSM at 3 and 9 month timepoints.
The study plan to enroll 180 total participants (120 in the randomized controlled trial and 60 in preliminary interviews) over the four year study period.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30322
- Emory University 1518 Clifton Rd
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age <= 29 years and >= 18 years
- Self-identify as Black/African-American (inclusive of multiracial identities)
- Male sex at birth
- Endorse history of sex with men ever (inclusive of gay and bisexual men)
- HIV-positive (self-reported by participant and confirmed by medical record)
- Able and willing to provide written consent and participate in surveys, interviews, and/or group intervention
Exclusion Criteria:
- Age < 18 years or >= 30 years
- Unwilling or unable to provide written informed consent
- Enrollment in one phase of the study is an exclusion criteria for enrollment in other phases
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: social capital intervention
This group will receive intervention developed from Phase 1 study and based on photovoice project
|
The social capital intervention will focus on developing skills and group-work that culminate in participant-derived photovoice projects.
Each group of YBMSM will be encouraged to complete a 30 day photovoice challenge.
The 30 day challenge is based on a prior community action project done as a part of our Centers for AIDS Research (CFAR)-funded research, which was a Photovoice project conducted by Dr. Hussen.
Photovoice is a participatory action research methodology in which groups of individuals from a population of interest are given cameras to document events, people and places of significance in their lives.
|
Aktiv komparator: group-based health promotion intervention
The intervention will be a modified version of "Health for Life" or H4L, which was used as a control arm intervention in a recently completed protocol of the Adolescent Trials Network which was co-chaired by Dr. Harper (University of Michigan)
|
The control arm will participate in a health education intervention that will be delivered in a group, but without a specific goal of creating group cohesion or social capital.
The intervention will be a modified version of "Health for Life" or H4L, which was used as a control arm intervention in a recently completed protocol of the Adolescent Trials Network which was co-chaired by Dr. Harper (University of Michigan).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in Modified Social Capital Scale (MSCS) between the social capital intervention group and group-based health promotion intervention
Tidsramme: Baseline, 4 months after beginning intervention, 10 months after beginning intervention
|
Modified Social Capital Scale (MSCS) is an In-Depth Interview Guide that asks questions about social capital and engagement in care.
The scale is recently modified, pilot tested, and validated Chen's Social Capital Scale.
The instrument contained 10 composite items based on 42 items for assessing personally owned social capital, including bonding and bridging capitals.
The questionnaire is a open ended questionnaire with probe questions.
The scale contains subscales for bonding and bridging capital, and it also contains items that specify sources (including family, friends, and lesbian, gay, bisexual, and transgender (LGBT) organizations) and types of support (e.g.
emotional support, instrumental support and informational support).
The data will be transcribed verbatim by a professional business transcription service.
Thematic analysis using a combination of inductive and deductive coding will be conducted to analyze the score.
|
Baseline, 4 months after beginning intervention, 10 months after beginning intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in viral load suppression measured as copies/ml at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Tidsramme: Baseline, 4 months and 10 months
|
Viral load values will be extracted from the participants' electronic medical records (EMR).
Viral load refers to the number of viral particles found in each millilitre of blood.
Viral load tests measure the amount of HIV's genetic material in a blood sample.
The results of a viral load test are described as the number of copies of HIV RNA in a millilitre of blood.
The viral load test should consistently detect and measure virus levels down to 50 copies/mL, have a high specificity and provide reproducible results.
The technologies used are advanced and very sensitive for measuring the amount of HIV genetic material present in the blood.
|
Baseline, 4 months and 10 months
|
Change in number of receiving two or more cluster of differentiation 4 (CD4) tests at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Tidsramme: Up to 10 months
|
Retention in Care will be measured by determining receiving two or more cluster of differentiation 4 (CD4) tests.
This information will be gathered from subject's electronic medical record
|
Up to 10 months
|
Number of HIV visits at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Tidsramme: Up to 10 months
|
Retention in Care will be measured by determining participation in continuous care, that is, at least two or more routine HIV visits at least three months apart.
This information will be gathered from subject's electronic medical record
|
Up to 10 months
|
Change in subjects self report to question at baseline, post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Tidsramme: Baseline and 10 months
|
Adherence to antiretroviral medications will be measured using a composite of single item self-report question and pharmacy refill records that will be conducted and evaluated at baseline and at 9 months.
|
Baseline and 10 months
|
Number of viral load tests at post-intervention 3 months and 9 months between the social capital intervention group and group-based health promotion intervention
Tidsramme: Up to 10 months
|
Retention in Care will be measured by determining receiving two or more viral load tests.
This information will be gathered from subject's electronic medical record.
|
Up to 10 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Sophia Hussen, M.D., M.P.H., Emory University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB00088255
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med HIV-infektioner
-
University of Santiago de CompostelaOsteology FoundationRekruttering
-
Institut PasteurRekruttering
-
Universidad del DesarrolloAfsluttetHealthcare Associated InfectionChile
-
The University of Texas Health Science Center,...EurofinsAfsluttetOdontogen Deep Space Neck InfectionForenede Stater
-
Imelda Hospital, BonheidenAfsluttetHealthcare Associated InfectionBelgien
-
Centre Hospitalier Universitaire de NīmesRekrutteringÆldre | Healthcare Associated InfectionFrankrig
-
Centre Hospitalier Universitaire, AmiensAfsluttetHealthcare Associated Infection | IglerFrankrig
-
University of PennsylvaniaAfsluttetAntimikrobiel resistensForenede Stater, Botswana
-
University of Maryland, BaltimoreVA Office of Research and DevelopmentAfsluttetMenneskelig mikrobiomForenede Stater
-
Universidad Autonoma de Nuevo LeonUkendtSundhedsrelaterede infektioner
Kliniske forsøg med social capital intervention
-
University of Illinois at Urbana-ChampaignAfsluttetAldring | Mild kognitiv svækkelse | Alder godtForenede Stater
-
National Research University Higher School of EconomicsStanford UniversityIkke rekrutterer endnuMeddelelse | Vaccine tøvenDen Russiske Føderation
-
Arcispedale Santa Maria Nuova-IRCCSAfsluttet
-
Canisius CollegeRekrutteringAutistisk lidelseForenede Stater
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)AfsluttetMenstruationsstemningsforstyrrelserForenede Stater
-
University of California, San DiegoAfsluttet
-
University of British ColumbiaVancouver Foundation; Inner-City Women's Initiatives SocietyTilmelding efter invitationEnsomhed | Social støtte | Social isolationCanada
-
Tel Aviv UniversityMinistry for Senior Citizens, IsraelAfsluttet
-
Swinburne University of TechnologyMelbourne Health; The Alfred; St Vincent's Hospital Melbourne; Austin Health; Eastern Health og andre samarbejdspartnereAfsluttetPsykotiske lidelser | Skizofreni | Affektive lidelser, psykotiskeAustralien
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Rekruttering